Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glyburide vs Metformin for Fetal Growth in Gestational Diabetes
NCT02091336Phase 4Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in gestational diabetes mellitus (GDM) comparing Glyburide Arm with Metformin Arm (2 arms). Primary endpoint: Fetal growth and large for gestational age index up to 9 months. Status: unknown.
02
Drugs
glibenclamidemetformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT02091336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091336.